Protinhi Therapeutics
Nijmegen
About Protinhi Therapeutics
Protinhi Therapeutics is a preclinical stage biotech company developing antivirals against viral threats like dengue, westnilevirus, covid etc.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Last round: Grant (Oct 2022)
- Website: protinhi.com
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/protinhi-therapeutics-141179 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.